SCHEMBL8240209

SCHEMBL8240209

CN(Cc1cc(NC(=O)CCCc2ccc(B(O)O)cc2)ccc1S(C)(=O)=O)C(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
NFKB1 P19838 1/20 0.38
MAPK1 P28482 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
MCL1 Q07820 1/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
POLB P06746 1/20 0.36
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
LMNA P02545 1/20 0.35
GLS O94925 1/20 0.35
TRPV1 Q8NER1 3/20 0.35
HDAC8 Q9BY41 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13631350 0.92 NPC1 (0.38) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL3861468 0.92 NPC1 (0.38) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL3859072 0.91 NPC1 (0.37) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL8233817 0.90 NPC1 (0.39) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL13683207 0.82 MEN1 (0.42) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL13631867 0.82 NPC1 (0.38) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL13631544 0.82 CA1 (0.36) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL13331075 0.81 NPC1 (0.37) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL3861255 0.80 CA1 (0.35) NPC1RAB9AALDH1A1SMN1; SMN2CA1
SCHEMBL8242485 0.78 CYP1A2 (0.36) NPC1RAB9AALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007076431-A1 MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-05 WO disclosed